FDA Adverse Event Malfunction Summary report: N

COAGUCHEK ® XS SYSTEM

MDR report key: 2121102 · Received June 13, 2011

Report

Report Number
1823260-2011-03199
Event Type
Malfunction
Date Received
June 13, 2011
Date of Event
June 1, 2011
Report Date
August 22, 2011
Manufacturer
ROCHE DIAGNOSTICS
Product Code
GJS
PMA / PMN Number
K062925
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

IT WAS UNKNOWN IF THE INITIAL REPORTER SENT REPORT TO THE FDA.

Description of Event or Problem · 1

CALLER TESTED 2.9 INR ON THE COAGUCHEK XS SYSTEM WHILE A COMPARISON LAB RETURNED AS 2.2 INR. NO ACTIONS TAKEN BASED ON DEVICE RESULT. NO ADVERSE EVENT REPORTED. REQUESTED RETURN OF SUSPECT HOWEVER CALLER NO LONGER HAS THE TEST STRIPS; REPLACEMENT WAS SENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COAGUCHEK ® XS SYSTEM PROTHROMBIN TIME TEST STRIPS GJS ROCHE DIAGNOSTICS NA 20131222

Patients

Seq Age Sex Outcome Treatment
1 073 YR FUROSEMIDE DAILY| LISINOPRIL| PROTONIX| CALCIUM| SIMVASTATIN| TRAVATAN EYE DROPS| ATENOLOL| "GELATIN" DAILY| AMLODIPINE| AORTIC VALVE REPLACEMENT| WARFARIN| DORZOLAMIDE/TIMOLOL| OCUVITE PRESERVISION| POTASSIUM CHLORIDE ER DAILY| VITAMIN D3| FERROUS SULFATE| CLONIDINE| COLACE| ISOSORBIDE MONONITRATE